Ron Kocak - 01 Jul 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Reporting relationship: VP, Controller and PAO
Issuer ticker: RNXT
Reported as of: 01 Jul 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jul 2025, 16:45:30 UTC
Prior SEC filing: 16 Apr 2025
Source filing: View source filing
Reporting owner signature: /s/ Ronald Kocak

Key filing fact

Ron Kocak filed Form 4 for RenovoRx, Inc. (RNXT) on 03 Jul 2025.

Key facts

This page summarizes Ron Kocak's Form 4 filing for RenovoRx, Inc. (RNXT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jul 2025, 16:45.

Change

Previous filing in this sequence was filed on 16 Apr 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002011160 Primary reporting owner

Kocak Ron

Relationship: VP, Controller and PAO
Address: C/O RENOVORX, INC., 2570 W EL CAMINO REAL, SUITE 320, MOUNTAIN VIEW
Signature: /s/ Ronald Kocak
Signature date: 03 Jul 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RNXT transaction Derivative

Stock Option

Award

Transaction value: $0
Shares: +41,600
Change %
Price: $0.000000
Shares after: 41,600
Date: 01 Jul 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 41,600
Exercise price: $1.27
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of 41,600 incentive stock options under the Issuer's Amended and Restated 2021 Omnibus Equity Incentive Plan (the "Plan") to the Reporting Person, which award was approved by the Compensation Committee of the Issuer's Board of Directors on July 1, 2025. Such award represents a number of options previously allocated to the Reporting Person for services rendered, the issuance of which was contingent upon the availability of shares under the Plan. Such availability became effective upon stockholder approval of an increase in the shares reserve at the Issuer's annual meeting of stockholders held on June 24, 2025. The options vest over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The option will only become exercisable when there is an effective registration statement covering the shares underlying the option. The option will become fully vested on January 1, 2029, and will expire on July 1, 2035.